Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Alzheimer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/156720512799015064PMID 22329649PMCID PMC4097094
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• 2013 Alzheimer's disease facts and figures

  2013cited by this paper
• Pioglitazone

  2012cited by this paper
• Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer’s disease

  2011cited by this paper
• GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease

  2010cited by this paper
• Actions of adiponectin on the excitability of subfornical organ neurons are altered by food deprivation.

  2010cited by this paper
• Leptin Reduces Pathology and Improves Memory in a Transgenic Mouse Model of Alzheimer's Disease

  2010cited by this paper
• Cardiovascular and metabolic effects of ghrelin.

  2010cited by this paper
• Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease.

  2010cited by this paper
• “Control” laboratory rodents are metabolically morbid: Why it matters

  2010cited by this paper
• Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

  2010cited by this paper
• Ghrelin receptor signaling: a promising therapeutic target for metabolic syndrome and cognitive dysfunction.

  2010cited by this paper
• Obesity and metabolic syndrome in 7-9 years-old Portuguese schoolchildren

  2010cited by this paper
• Transferrin Fusion Technology: A Novel Approach to Prolonging Biological Half-Life of Insulinotropic Peptides

  2010cited by this paper
• Expression of the Ghrelin and Neurotensin Systems is Altered in the Temporal Lobe of Alzheimer's Disease Patients

  2010cited by this paper
• Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice.

  2010cited by this paper
• Leptin and ghrelin concentrations and weight loss in Parkinson’s disease

  2010cited by this paper
• 2010 Alzheimer's disease facts and figures

  2010cited by this paper
• Circulating Brain-Derived Neurotrophic Factor and Indices of Metabolic and Cardiovascular Health: Data from the Baltimore Longitudinal Study of Aging

  2010cited by this paper
• PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons.

  2009cited by this paper
• Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes.

  2009cited by this paper
• Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease.

  2009cited by this paper
• Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease

  2009influential reference
• Brain-Derived Neurotrophic Factor Reduces Amyloidogenic Processing through Control of SORLA Gene Expression

  2009cited by this paper
• Association between late-life body mass index and dementia

  2009cited by this paper
• Hypoadiponectinemia: a risk factor for metabolic syndrome.

  2009cited by this paper
• A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease.

  2009cited by this paper
• Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells.

  2009cited by this paper
• Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer’s disease patients

  2009cited by this paper
• A metabolic and functional overview of brain aging linked to neurological disorders

  2009cited by this paper
• Dietary intake in adults at risk for Huntington disease

  2009cited by this paper
• Cognitive enhancing effects of ghrelin receptor agonists

  2009cited by this paper
• Weight loss, body fat mass, and leptin in Parkinson's disease

  2009cited by this paper
• Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells.

  2009cited by this paper
• Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors

  2009cited by this paper
• Growth Factor Signals in Neural Cells

  2009cited by this paper
• Daily energy expenditure, physical activity, and weight loss in Parkinson's disease patients

  2009cited by this paper
• Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?

  2009cited by this paper
• Ghrelin Promotes and Protects Nigrostriatal Dopamine Function via a UCP2-Dependent Mitochondrial Mechanism

  2009cited by this paper
• Physical activity, diet, and risk of Alzheimer disease.

  2009cited by this paper
• Adiponectin and energy homeostasis: consensus and controversy.

  2009cited by this paper
• Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion.

  2008cited by this paper
• Caloric restriction: impact upon pituitary function and reproduction.

  2008cited by this paper
• Diet‐induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle‐aged rats

  2008cited by this paper
• New insights into brain BDNF function in normal aging and Alzheimer disease.

  2008cited by this paper
• PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease

  2008cited by this paper
• iTRAQ Analysis of Complex Proteome Alterations in 3xTgAD Alzheimer's Mice: Understanding the Interface between Physiology and Disease

  2008cited by this paper
• Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.

  2008cited by this paper
• Fear of health insurance loss among individuals at risk for Huntington disease

  2008cited by this paper
• Neuroprotective actions of leptin on central and peripheral neurons in vitro.

  2008cited by this paper
• Weight loss in neurodegenerative disorders

  2008cited by this paper
• Diabetes in Patients With Idiopathic Parkinson's Disease

  2008cited by this paper
• Cognitive dysfunction and diabetes mellitus.

  2008cited by this paper
• Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells.

  2008cited by this paper
• Glucagon-like Peptide-1 (GLP-1) Diminishes Neuronal Degeneration and Death Caused by NGF Deprivation by Suppressing Bim Induction

  2008cited by this paper
• Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.

  2008cited by this paper
• Reduced energy intake: the secret to a long and healthy life?

  2007cited by this paper
• Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus.

  2007cited by this paper
• Widespread Disruption of Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy at Its Target Genes in Huntington's Disease

  2007cited by this paper
• Update on the genetics of Parkinson's disease

  2007cited by this paper
• Huntington's disease.

  2007cited by this paper
• Body mass index and risk of Parkinson's disease: a prospective cohort study.

  2007cited by this paper
• Early Energy Deficit in Huntington Disease: Identification of a Plasma Biomarker Traceable during Disease Progression

  2007cited by this paper
• Influence of ghrelin on food intake and energy homeostasis

  2007cited by this paper
• Body mass index in midlife and risk of Alzheimer disease and vascular dementia.

  2007influential reference
• Leptin: a diverse regulator of neuronal function

  2007cited by this paper
• Systemic and Brain Metabolic Dysfunction as a New Paradigm for Approaching Alzheimer’s Dementia

  2007cited by this paper
• Role of leptin in immunity.

  2007cited by this paper
• Role of brain-derived neurotrophic factor in Huntington's disease.

  2007cited by this paper
• APOE genotype effects on alzheimer’s disease onset and epidemiology

  2007cited by this paper
• The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments

  2006cited by this paper
• Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

  2006cited by this paper
• Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat.

  2006cited by this paper
• Weight loss in Parkinson’s disease

  2006cited by this paper
• Wild‐type huntingtin protects neurons from excitotoxicity

  2006cited by this paper
• Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells.

  2006cited by this paper
• Effects of leptin on memory processing.

  2006cited by this paper
• Protein twists and turns in Alzheimer disease

  2006cited by this paper
• Ghrelin controls hippocampal spine synapse density and memory performance

  2006influential reference
• Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.

  2006cited by this paper
• Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice.

  2006cited by this paper
• Huntington Disease in a 9-Year-Old Boy: Clinical Course and Neuropathologic Examination

  2006cited by this paper
• Leptin and its role in hippocampal synaptic plasticity.

  2006cited by this paper
• Caloric restriction and intermittent fasting: two potential diets for successful brain aging.

  2006cited by this paper
• Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice

  2005cited by this paper
• The pathobiology of diabetic complications: a unifying mechanism.

  2005cited by this paper
• Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.

  2005cited by this paper
• Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes.

  2005cited by this paper
• Predicting Alzheimer’s Disease in the Baltimore Longitudinal Study of Aging

  2005cited by this paper
• Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington’s disease is not improved by treatment with hypoglycaemic agents

  2005cited by this paper
• Axonal transport failure in neurodegenerative disorders: the case of Huntington's disease.

  2005cited by this paper
• The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis.

  2005cited by this paper
• Energy balance in early-stage Huntington disease.

  2005cited by this paper
• Adiponectin, an adipocyte-derived protein.

  2005cited by this paper
• Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta

  2005cited by this paper
• Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.

  2005cited by this paper
• Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease.

  2005cited by this paper
• Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.

  2005cited by this paper

• Silencing of the Metabolic Gene HKDC1 Is Associated With Aging and Neurodegeneration in Mice and Humans.

  2026cites this paper
• The rhythm of decline: Circadian disruption in neurodegeneration

  2025cites this paper
• Nrf2 Activation as a Therapeutic Target for Flavonoids in Aging-Related Osteoporosis

  2025cites this paper
• Benchmarking the AI-based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,170 people

  2025cites this paper
• Basal metabolic rate predicts dementia in community-dwelling older adults: a 5-year longitudinal study

  2025cites this paper
• Multi-marker discovery for mild cognitive impairment in metabolomics using machine learning with a global surrogate model via partial least squares

  2025cites this paper
• Alzheimer’s disease risk prediction using machine learning for survival analysis with a comorbidity-based approach

  2025cites this paper
• Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer's disease.

  2025cites this paper
• G protein-coupled receptor digital twins for precision and personalized medicine

  2025cites this paper
• TMBIM-2 orchestrates systemic mitochondrial stress response via facilitating Ca2+ oscillations.

  2025cites this paper
• Restriction of individual branched-chain amino acids has distinct effects on the development and progression of Alzheimer’s disease in 3xTg mice

  2025cites this paper
• Genetic convergence in brain aging and neurodegeneration: from cellular mechanisms to therapeutic targets

  2025cites this paper
• Genetically encoded biosensors of metabolic function for the study of neurodegeneration, a review and perspective

  2025cites this paper
• Dose-dependent evaluation of chronic oleocanthal on metabolic phenotypes and organ toxicity in 5xFAD mice

  2025cites this paper
• Insights into therapeutic approaches for the treatment of neurodegenerative diseases targeting metabolic syndrome

  2025cites this paper
• Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosis

  2025cites this paper
• EMERGING THE ROLE OF TRACE MINERALS AND VITAMINS IN ALZHEIMER'S DISEASE

  2024cites this paper
• Calcium Signalling in Neurological Disorders, with Insights from Miniature Fluorescence Microscopy

  2024cites this paper
• Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer's disease

  2024cites this paper
• Structural Brain Alterations in Metabolic Syndrome: A Comprehensive MRI Volumetric Analysis of Subcortical and Associated Structures

  2024cites this paper
• The Beneficial Effects of GLP-1 Receptor Agonists Other than Their Anti-Diabetic and Anti-Obesity Properties

  2024cites this paper
• The Crosstalk Between Amyloid-β, Retina, and Sleep for the Early Diagnosis of Alzheimer’s Disease: A Narrative Review

  2024cites this paper
• Evaluation of the Glymphatic System in Schizophrenia Spectrum Disorder Using Proton Magnetic Resonance Spectroscopy Measurement of Brain Macromolecule and Diffusion Tensor Image Analysis Along the Perivascular Space Index.

  2024cites this paper
• Regulator of Lipid Metabolism NHR-49 Mediates Pathogen Avoidance through Precise Control of Neuronal Activity

  2024cites this paper
• 2-Amino-6-ethoxy-4-arylpyridine-3,5-dicarbonitrile Scaffolds as Potential Acetylcholinesterase and Butyrylcholinesterase Inhibitors

  2024cites this paper
• Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's Disease.

  2024cites this paper
• Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming.

  2024cites this paper
• Iron accumulation/overload and Alzheimer's disease risk factors in the precuneus region: A comprehensive narrative review

  2024cites this paper
• The effect of Neuropeptide Y Y2 receptor blockade on memory impairment and autophagy in a rat model of Alzheimer’s disease

  2024cites this paper
• Effect of simultaneous application of adenosine A1 receptor agonist and A2A receptor antagonist on memory, inflammatory factors, and PSD-95 in lipopolysaccharide-induced memory impairment.

  2024cites this paper
• Metabolomics profiling reveals distinct, sex‐specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease

  2024cites this paper
• Tauroursodeoxycholic acid: a bile acid that may be used for the prevention and treatment of Alzheimer’s disease

  2024cites this paper
• Neurohistopathological Alterations Induced by Clitoria Ternatea and Emblica Officinalis Extracts in Diabetic Male Wistar Rats

  2024cites this paper
• Disruption of mitochondrial pyruvate oxidation in dorsal root ganglia drives persistent nociceptive sensitization and causes pervasive transcriptomic alterations

  2024cites this paper
• Huntington’s Disease Drug Development: A Phase 3 Pipeline Analysis

  2023cites this paper
• The toxic metal hypothesis for neurological disorders

  2023cites this paper
• Role of Nrf2 in Oxidative Stress, Neuroinflammation and Autophagy in Alzheimer's Disease: Regulation of Nrf2 by Different Signaling Pathways.

  2023cites this paper
• Neurohistopathological Alterations Induced by Theobroma Cacao and Camellia Sinensis Extracts in Diabetic Male Wistar Rats

  2023cites this paper
• Intracerebroventricular Injection of MHY1485 Blocked the Beneficial Effect of Adiponectin on Aversive Memory in the STZ Model of Dementia.

  2023cites this paper
• Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types

  2023cites this paper
• Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

  2023cites this paper
• Alteration of Metabolic Profiles during the Progression of Alzheimer’s Disease

  2023cites this paper
• Synthesis of Some Benzothiazole Derivatives Based on 3‐Hydroxypyridine‐4‐one and Benzaldehyde and Evaluation of Their β‐Amyloid Aggregation Inhibition Using both Experimental Methods and Molecular Dynamic Simulation

  2023cites this paper
• Effect of Daily Coffee Consumption on the Risk of Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2023cites this paper
• Hexosamine Biosynthetic Pathway and O-GlcNAc cycling of Glucose Metabolism in Brain Function and Disease.

  2023cites this paper
• Assessing adipokines as potential biomarkers of dementia, Alzheimer's disease, and mild cognitive impairment: A systematic review and meta‐analysis

  2023cites this paper
• GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process

  2023cites this paper
• Unraveling the Mechanism of Immunity and Inflammation Related to Molecular Signatures Crosstalk Among Obesity, T2D, and AD: Insights From Bioinformatics Approaches

  2023cites this paper
• Lactate Metabolism, Signaling, and Function in Brain Development, Synaptic Plasticity, Angiogenesis, and Neurodegenerative Diseases

  2023cites this paper
• Apoptosis Genes as a Key to Identification of Inverse Comorbidity of Huntington’s Disease and Cancer

  2023cites this paper
• How Can Insulin Resistance Cause Alzheimer’s Disease?

  2023cites this paper
• Important Cells and Factors from Tumor Microenvironment Participated in Perineural Invasion

  2023cites this paper
• Influence of the Mediterranean Diet on Healthy Aging

  2023cites this paper
• Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence.

  2023cites this paper
• Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease

  2023cites this paper
• Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer’s disease

  2023cites this paper
• Astrocyte metabolism and signaling pathways in the CNS

  2023cites this paper
• The oDGal Mouse: A Novel, Physiologically Relevant Rodent Model of Sporadic Alzheimer’s Disease

  2023cites this paper
• Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming

  2023cites this paper
• Dissecting the Neuronal Contributions of the Lipid Regulator NHR-49 Function in Lifespan and Behavior in C. elegans

  2023cites this paper
• Insights into the promising prospect of medicinal chemistry studies against neurodegenerative disorders.

  2023cites this paper
• Gold nanoparticles application to the treatment of brain dysfunctions related to metabolic diseases: evidence from experimental studies

  2022cites this paper
• Intersection of the Orphan G Protein-Coupled Receptor, GPR19, with the Aging Process

  2022cites this paper
• Adiponectin, the adiponectin paradox, and Alzheimer’s Disease: Is this association biologically plausible?

  2022cites this paper
• Opposite Roles of Co-enzyme Q10 and Formaldehyde in Neurodegenerative Diseases

  2022cites this paper
• PROtein enriched MEDiterranean diet to combat undernutrition and promote healthy neuroCOGnitive ageing in older adults: The PROMED‐COG consortium project

  2022cites this paper
• Circulating adiponectin levels, expression of adiponectin receptors, and methylation of adiponectin gene promoter in relation to Alzheimer’s disease

  2022cites this paper
• The Hidden Notes of Redox Balance in Neurodegenerative Diseases

  2022cites this paper
• Identification of differentially expressed novel tau associated proteins in transgenic AD model of Drosophila - a proteomic and in silico Approach

  2022cites this paper
• Role of Seipin in Human Diseases and Experimental Animal Models

  2022cites this paper
• Uncovering the system vulnerability and criticality of human brain under evolving neuropathological events in Alzheimer’s disease

  2022cites this paper
• Conductor of the Astrocyte-Neuron Metabolic Orchestra

  2022cites this paper
• Challenges of repurposing tetracyclines for the treatment of Alzheimer’s and Parkinson’s disease

  2022cites this paper
• JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function

  2022cites this paper
• Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer’s Disease

  2022cites this paper
• MOLECULAR MECHANISM OF PROMOTION, PROGRESSION AND POSSIBLE THERAPIES OF ALZHEIMER'S DISEASE

  2022cites this paper
• Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis

  2022cites this paper
• Sodium-glucose cotransporter 2 inhibitors and neurological disorders: a scoping review

  2022cites this paper
• Human neural cell type‐specific extracellular vesicle proteome defines disease‐related molecules associated with activated astrocytes in Alzheimer's disease brain

  2022cites this paper
• Inflammation driven metabolic regulation and adaptation in macrophages.

  2022cites this paper
• The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease

  2022cites this paper
• Fecal Microbiota Transplantation Reduces Pathology and Improves Cognition in a Mouse Model of Alzheimer’s Disease

  2022cites this paper
• Intermittent cytomegalovirus infection alters neurobiological metabolism and induces cognitive deficits in mice

  2022cites this paper
• Rewiring the Three-Carbon Metabolism Abrogates Multiple MAPK-Induced Cellular Dysfunctions During Metabolic Disorder

  2021cites this paper
• Genetic overlap between Alzheimer's disease and blood lipid levels.

  2021cites this paper
• Neuronal mitochondrial dysfunction in a cellular model of circadian rhythm disruption is rescued by donepezil.

  2021cites this paper
• Curcugreen Treatment Prevented Splenomegaly and Other Peripheral Organ Abnormalities in 3xTg and 5xFAD Mouse Models of Alzheimer’s Disease

  2021cites this paper
• Circadian changes in Alzheimer's disease: Neurobiology, clinical problems, and therapeutic opportunities.

  2021cites this paper
• Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease

  2021cites this paper
• Mitochondrial remodelling—a vicious cycle in diabetic complications

  2021cites this paper
• Alcohol consumption in the general population is associated with structural changes in multiple organ systems

  2021cites this paper
• Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming

  2021cites this paper
• Unveiling the Metabolic Modulatory Effect of Anthocyanin and Gut Microbiota Involvement

  2021cites this paper
• GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease

  2021cites this paper
• Super‐Resolution Vibrational Imaging Using Expansion Stimulated Raman Scattering Microscopy

  2021cites this paper
• Modulatory role of the Endocannabinoidome in the pathophysiology of the gastrointestinal tract.

  2021cites this paper
• Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration

  2021cites this paper
• Alcohol consumption in the general population is associated with structural changes in multiple organ systems: A population-based study in UK Biobank

  2021cites this paper
• Deciphering the key mechanisms leading to alteration of lipid metabolism in Drosophila model of Huntington's disease.

  2021cites this paper
• Novel graph theoretic biological pathway network analytics methods for analyzing and discovering Alzheimer’s disease related genes

  2021cites this paper